C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2002
10/17/2002	WO2002081631A2 Uncoupled productive and catabolic host cell pathways
10/17/2002	WO2002081626A2 D-hydantoinase from ochrobactrum anthropi
10/17/2002	WO2002081625A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	WO2002081624A2 Functional genetic tests of dna mismatch repair
10/17/2002	WO2002081510A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081501A1 Crystals of proteasome-nhibitor complex
10/17/2002	WO2002081498A2 Novel proteins and nucleic acids encoding same
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002080846A2 Epothilone derivatives and methods for making and using the same
10/17/2002	WO2002052024A3 Elongase promoters
10/17/2002	WO2002042440A3 Regulation of plant growth by modifying the expression of a putative trna-isope ntenyl transferase
10/17/2002	WO2002036754A3 Nucleotide and polypeptide sequence of human lysosomal acid lipase
10/17/2002	WO2002022869A3 Directed evolution method
10/17/2002	WO2002020800A9 16658, 14223, and 16002, NOVEL HUMAN KINASES AND USES THEREFOR
10/17/2002	WO2002020548A9 Monocot seeds with increased lignan content
10/17/2002	WO2002012463A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
10/17/2002	WO2002006457A3 Novel lipase genes
10/17/2002	WO2002006326A3 62088, a human nucleoside phosphatase family member and uses thereof
10/17/2002	WO2002004645A3 A second human heparanase, and splice variants thereof, with a predominant expression in skeletal muscle, heart and pancreas
10/17/2002	WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002	WO2001085968A3 Production of conjugated linoleic and linolenic acids in plants
10/17/2002	WO2001075077A3 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
10/17/2002	WO2001072975A9 Human methyl transferase family member, 25552, and uses thereof
10/17/2002	WO2001060986A9 Esterase enzymes having selective activity
10/17/2002	WO2001055410A9 Ceramidase compositions and methods based thereon
10/17/2002	WO2001054712A9 Compositions and methods for the early diagnosis of ovarian cancer
10/17/2002	WO2001040497A3 Method for obtaining nucleic acids from an environment sample
10/17/2002	US20020152502 Transgenic plant; tolerance of environment stresses
10/17/2002	US20020152500 Tissue-preferred promoter from maize
10/17/2002	US20020152497 Nucleic acid fragments encoding proteins involved in stress response
10/17/2002	US20020152495 Plants having seedless fruit
10/17/2002	US20020152494 Adjustment chromosome sequences; transgenic animal
10/17/2002	US20020152493 Transgenic mice containing PTP36 tyrosine phosphatase gene disruptions
10/17/2002	US20020152482 Mice with combined disruption of Gpx1 and Gpx2 genes have growth retardation, hypothermia, and colitis
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020151707 Soluble, fused major histocompatability complexes and peptide complexes; glutamate decarboxylase; autoimmunity
10/17/2002	US20020151703 Process for producing microbial transglutaminase
10/17/2002	US20020151702 Aggrecanase molecules
10/17/2002	US20020151699 Transgenic; gene expression; cloning; isolation of ricinoleic acid from oleic acid in developing endosperm of castor
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151684 Fusion protein and uses thereof
10/17/2002	US20020151592 Long term administration of L-arginine, L-lysine or salts, and a polypeptide precursor which enhance the level of endogenous nitric oxide or intermediates in the NO induced relaxation pathway in the host
10/17/2002	US20020151497 Inhibitors comprise sequences derived from specific regions of the Lyn-kinase
10/17/2002	US20020151482 Administering to a bird or mammal a PRG-B polypeptide as an angiogenesis inhibitor; antitumor, -carcinogenic, -neoplastic and -arthritic agents; diabetic retinopathy; cancer of the lung, breast, or prostate gland; gene therapy
10/17/2002	US20020151479 Nucleic acids, proteins, and antibodies
10/17/2002	US20020151471 Factor VII glycoforms
10/17/2002	US20020151450 Obtainable from stachybotrys with specific amino acid sequence are useful in modifying the color associated with dyes and colored compounds
10/17/2002	US20020151073 Transcription factor
10/17/2002	US20020151072 Chimeric mutational vectors
10/17/2002	US20020151068 Compositions and methods for the diagnosis and treatment of organophosphate toxicity
10/17/2002	US20020151058 Vector construction by host cell-mediated recombination
10/17/2002	US20020151047 Nucleotide sequences coding polypeptide for use in human therapeutics, diagnostics and pharmocology
10/17/2002	US20020151036 Process for producing cytidine diphosphate choline
10/17/2002	US20020151035 Nucleotide sequences coding enzymatic polypeptide for use in generation of medicines
10/17/2002	US20020151034 Stable zymomonas mobilis xylose and arabinose fermenting strains
10/17/2002	US20020151031 Mycobacterial isocitrate lyase gene and uses thereof
10/17/2002	US20020151029 Human serine protease
10/17/2002	US20020151028 Structure-based drug design for Ulp1 protease substrates
10/17/2002	US20020151026 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of tissue injuries
10/17/2002	US20020151024 DNA encoding mammalian phosphodiesterases
10/17/2002	US20020151023 GMP synthetase and gene coding for the same
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151020 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/17/2002	US20020151019 Enzymatic polypeptide for use in the fatty acid biosynthesis in plants
10/17/2002	US20020151018 Stearoyl-CoA desaturase gene promoter
10/17/2002	US20020151017 Methods for obtaining a polynecleotide encoding a polypeptide having a rubisco activity
10/17/2002	US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002	US20020151014 Modified bioluminescent proteins and their use
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151010 Nucleotide sequences coding enzymatic polypeptide for use in the genetically engineered cells for prevention of feedback inhibition
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020151007 Nucleotide seauemces coding enzymatic polypeptide for use in the treatment, prevention of tumor
10/17/2002	US20020151006 Methods of ligating expressed proteins
10/17/2002	US20020151005 53070, a novel human protein kinase family member and uses thereof
10/17/2002	US20020151002 Sinapoylglucose:malate sinapoyltransferase form malate conjugates from benozic acid glucosides
10/17/2002	US20020151000 Process for producing trans-4-hydroxy-L-proline
10/17/2002	US20020150999 Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria
10/17/2002	US20020150997 Generating enzymatic polypeptide; obtain nuclelotide sequences, adjust sequences, express sequences in cell, monitor polypeptide activity
10/17/2002	US20020150995 Methods for producing sialyloligosaccharides in a dairy source
10/17/2002	US20020150989 Human tumor necrosis factor receptor
10/17/2002	US20020150984 Peptides for activation and inhibition of deltaPKC
10/17/2002	US20020150983 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same
10/17/2002	US20020150982 Generating mutant desaturase; obtain nucleotide sequence coding desaturase, mutate, obtain cell, transform with mutant sequences, express mutant nucleotide sequences in cell, recover mutant protein
10/17/2002	US20020150981 Methods for producing highly phosphorylated lysosomal hydrolases
10/17/2002	US20020150978 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumor, aberrant angiogenesis, cardiovascular, arthritis, nephritis, nervous system, vision, mouth, lung, skin, ulcer and gastrointestinal disorders
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150969 Generating peptidyl prolyl cis-trans isomerases; obtain cell, transform with vector containing isomerase, express vector, evaluate activity of enzyme
10/17/2002	US20020150963 Map
10/17/2002	US20020150956 Novel tig
10/17/2002	US20020150953 Detecting modulators of muscle protein activity; obtain mixture of calcineurin and muscle protein, monitor binding, incubate with modulator, monitor adjustment in binding activity compare to control
10/17/2002	US20020150943 Genotyping by mass spectrometric analysis of allelic fragments
10/17/2002	US20020150931 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder
10/17/2002	US20020150915 Promoter sequences
10/17/2002	US20020150910 33410, a novel human carboxylesterase family member and uses thereof
10/17/2002	US20020150908 Diagnosing and detecting cancer in mammals; obtain cells, isolate nucleotide sequences, detect hepsin nucleotide sequences, the presence of hepsin indicates hyperplasia
10/17/2002	US20020150902 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
10/17/2002	US20020150897 Method for detecting and isolating genes
10/17/2002	US20020150896 Diagnosis and treatment of diabetes; obtain nucleotide sequence sample from tissue, detect polymorphism, presence of polymorphsm indicates diabetes
10/17/2002	US20020150876 Detecting genetically engineered cells; obtain cells, incubate with nucleic acids, transform, detect expression of preferential genes, expression of genes indicates genetically engineered cells

1 ... 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 ... 1416